HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Schmid, C. Articles by Wiesli, P. Search for Related Content PubMed PubMed Citation Articles by Schmid, C. Articles by Wiesli, P. Related Collections Endocrinology and Metabolism

Effect of Thyroxine Replacement on Creatinine, Insulin-Like Growth Factor 1, Acid-Labile Subunit, and Vascular Endothelial Growth Factor

¹ Department of Internal Medicine, Division of Endocrinology and Diabetes, University Hospital of Zurich, CH-8091 Zurich, Switzerland

^aauthor for correspondence: fax 41-1-255-4447, e-mail peter.wiesli@dim.usz.ch

The first 20% of the full text of this article appears below.

Hypothyroidism is associated with endothelial dysfunction, arterial hypertension, and impaired kidney function (1)(2)(3). An increased serum creatinine and decreased glomerular filtration rate and renal blood flow have been described (2)(4)(5). These deleterious consequences may result from several mechanisms, including direct and indirect effects of thyroid hormones on blood vessels. Insulin-like growth factor 1 (IGF-1) and vascular endothelial growth factor (VEGF), growth factors with both local and systemic effects, may be involved as potential mediators. Hypothyroidism causes low concentrations of IGF-1, which can be normalized by thyroxine replacement therapy (6). IGF-1 is known to increase forearm blood flow and creatinine clearance in humans (7)(8)(9). VEGF increases endothelial nitric oxide synthase activity, contributing to the relaxing capacity of the renal vasculature (10)(11)(12)(13). Thus, both IGF-1 and VEGF may improve endothelial function and renal blood flow.

The purpose of this study was to test the effect of thyroxine therapy on serum creatinine, IGF-1, and VEGF in hypothyroid patients. Patients with newly diagnosed primary hypothyroidism who had been referred to the Division of Endocrinology and Diabetes at the University Hospital in Zurich between February 1998 and July 2002 were included in this prospective case series. Oral informed consent was obtained from all patients. Patients with neoplastic disease, secondary hypothyroidism, and thyroid cancer were excluded from the study because VEGF is often increased in patients with tumors, including tumors of the pituitary gland and the thyroid (14)(15).

All laboratory values were measured . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				Y. Debaveye, B. Ellger, L. Mebis, E. Van Herck, W. Coopmans, V. Darras, and G. Van den Berghe Tissue Deiodinase Activity during Prolonged Critical Illness: Effects of Exogenous Thyrotropin-Releasing Hormone and Its Combination with Growth Hormone-Releasing Peptide-2 Endocrinology, December 1, 2005; 146(12): 5604 - 5611. [Abstract] [Full Text] [PDF]